Long GV, Lipson EJ, Hodi FS, Ascierto PA, et al. Erratum: First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimumab in Advanced Melanoma: An Indirect Treatment Comparison Using RELATIVITY-047 and CheckMate 067 Trial Data. J Clin Oncol 2025 Mar 7:JCO2500452. doi: 10.1200/JCO-25-00452.
PMID: 40053890